Related Experiment Videos
[Prostate carcinoma cell lines and apoptosis: a review]
S Califice1, D Waltregny, V Castronovo
1Laboratoire de Recherche sur les Métastases, Pathologie B23, CHU B35, Sart-Tilman, Liège.
Revue Medicale De Liege
|January 22, 2005
Summary
Prostate cancer growth involves increased cell proliferation and inhibited apoptosis. Understanding molecular regulators of apoptosis in prostate cancer offers potential for new anti-cancer strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Context:
- Prostate cancer is a significant health issue in industrialized nations.
- Tumorigenesis is characterized by uncontrolled cell proliferation and resistance to programmed cell death (apoptosis).
Purpose:
- To review the molecular mechanisms regulating apoptosis in prostate cancer.
- To summarize the roles of key molecular actors in prostate cancer cell apoptosis.
- To evaluate the therapeutic potential of targeting these apoptotic pathways.
Summary:
- This review details apoptotic mechanisms and their investigation methods.
- It examines the (de)regulation of androgens, p53, Bcl-2 family proteins (Bcl-2, Bcl-xL, Bax), Akt, PTEN, Par-4, clusterin, caspases, and NF-kappaB in prostate adenocarcinoma.
- The therapeutic implications of these molecular players are appraised.
Impact:
- Enhanced understanding of apoptosis regulation in prostate cancer can lead to novel therapeutic strategies.
- Targeting specific apoptotic pathways may offer selective and effective treatments for prostate cancer.
- This review provides a comprehensive overview for researchers and clinicians.